HEPATOBILIARY MALIGNANCY
Clinical trials for HEPATOBILIARY MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEPATOBILIARY MALIGNANCY trials appear
Sign up with your email to follow new studies for HEPATOBILIARY MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common antidepressant boost cancer immunotherapy?
Disease control Recruiting nowThis study tests whether adding the antidepressant fluoxetine (Prozac) to standard immunotherapy can improve tumor control and survival in 240 people with advanced liver or gallbladder cancer who also have depression or anxiety. Participants will receive either fluoxetine or a pl…
Matched conditions: HEPATOBILIARY MALIGNANCY
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Glow-in-the-Dark dye helps surgeons spot hidden cancer
Diagnosis Recruiting nowThis study tests a dye called CYTALUX (pafolacianine) that attaches to cancer cells and glows under a special camera during surgery. About 50 adults with certain cancers (like esophageal, pancreatic, or gynecologic) will get the dye before surgery. The goal is to see if the glowi…
Matched conditions: HEPATOBILIARY MALIGNANCY
Phase: PHASE2 • Sponsor: John Waters • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC